| Page 1282 | Kisaco Research

Samtec

I loved the targeted approach for an event like this. I thought the calibre of attendees was appropriate for the event. It offered a great chance to network with industry leaders. 

Mythic

This year's AI Hardware Summit had a rock star lineup of speakers, and included a number of first ever disclosures of products and technologies. This is becoming a can't miss conference for the industry. 

Microsoft

Stellar keynote, interesting talks on "big problems" like throughput, AI model flexibility and energy consumption. Most of the relevant hardware startups were in attendance or presented, including a few new ones that I hadn't heard of! A good lineup. 

Moor Insights & Strategy

This event has quickly emerged as THE conference for all things fast and efficient for processing deep neural networks. The content is a nice blend of technology, solutions and company strategies. 

 

Adam Scragg

Head of Export Controls & Sanctions, Group Ethics & Compliance
Johnson Matthey (UK)

Adam Scragg

Head of Export Controls & Sanctions, Group Ethics & Compliance
Johnson Matthey (UK)

Adam Scragg

Head of Export Controls & Sanctions, Group Ethics & Compliance
Johnson Matthey (UK)

Intel

The AI Hardware Summit is one of the most unique conferences in the industry in the way that it maintains a strong technical depth on the talks and attracts industry leaders, from the big companies to up and coming startups. It is the only place where you can make the right business connections and learn from luminaries in the AI hardware space. 

Habana Labs

The AI Hardware Summit seems to be the best forum for serious AI hardware news and discussions among real influencers in the industry. This is one event where the level of technical know-how is at the right "level" for decision making in the AI data center - where the presentations, panels, discussions and networking opportunities are highly relevant. 

 

Justin Fallon

Co-Founder
Bolden Therapeutics

Justin Fallon

Co-Founder
Bolden Therapeutics

Justin Fallon

Co-Founder
Bolden Therapeutics
 

Sudhir Agrawal

Founder and President
Arnay Sciences

Sudhir Agrawal

Founder and President
Arnay Sciences

Sudhir Agrawal

Founder and President
Arnay Sciences
 

Martin Akerman

CTO
Envisagenics

Dr. Martin Akerman is the Co-founder and CTO of Envisagenics. He is the inventor of SpliceCore®, Envisagenics’ flagship platform born of his vision of applying machine learning to RNA information and discovering new drug targets in areas of unmet need. Martin trained as a post doctorate fellow with Dr. Adrian Krainer at Cold Spring Harbor Laboratory, where he helped in the development of Spinraza®, the first FDA-approved RNA therapeutic for treating Spinal Muscular Atrophy.

Martin Akerman

CTO
Envisagenics

Martin Akerman

CTO
Envisagenics

Dr. Martin Akerman is the Co-founder and CTO of Envisagenics. He is the inventor of SpliceCore®, Envisagenics’ flagship platform born of his vision of applying machine learning to RNA information and discovering new drug targets in areas of unmet need. Martin trained as a post doctorate fellow with Dr. Adrian Krainer at Cold Spring Harbor Laboratory, where he helped in the development of Spinraza®, the first FDA-approved RNA therapeutic for treating Spinal Muscular Atrophy. He received his PhD in Bioinformatics from Technion, Israel Institute of Technology, where he studied how RNA splicing can boost functionality of the human genome and trigger diseases.